$1.36
-0.02 (-1.45%)
Open$1.37
Previous Close$1.38
Day High$1.40
Day Low$1.34
52W High$3.09
52W Low$1.22
Volume—
Avg Volume194.4K
Market Cap259.04M
P/E Ratio14.26
EPS$0.13
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,816.9% upside
Current
$1.36
$1.36
Target
$39.67
$39.67
$29.46
$39.67 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 381.05M | 314.56M | 81.33M |
| Net Income | -36,397,130 | -27,040,958 | 15.27M |
| Profit Margin | -9.6% | -9.1% | 18.8% |
| EBITDA | -6,588,650 | -5,166,928 | 21.57M |
| Free Cash Flow | — | — | 16.42M |
| Rev Growth | +21.1% | +21.1% | -3.5% |
| Debt/Equity | 0.22 | 0.22 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |